Sex Differences in Body Composition and MASLD in Children With Overweight and Obesity
- PMID: 39945203
- PMCID: PMC12147431
- DOI: 10.1111/apa.70026
Sex Differences in Body Composition and MASLD in Children With Overweight and Obesity
Abstract
Aim: To explore the relationships between body composition, indices of hepatic fibrosis, and sonographic evidence of hepatic steatosis in children with overweight and obesity.
Methods: One hundred and seventy individuals (age 12.7 ± 3.4 years, 38.2% boys) with overweight/obesity (BMI z-score 2.02 ± 0.54) underwent bioelectrical impedance analysis (fat percentage, truncal-to-total fat ratio, muscle-to-fat ratio [MFR]). Hepatic assessments included ultrasonography to detect liver steatosis, alanine transaminase (ALT), aspartate aminotransferase (AST)/ALT ratio, and nonalcoholic fatty liver disease fibrosis score (NFS). A forward logistic regression model, adjusting for sex, age, and socio-economic position, was conducted.
Results: The odds for sonographic hepatic steatosis increased by 3.8-fold for each SD decrease in MFR z-score (OR = 0.263, 95% CI [0.067-1.031], p = 0.05). The strongest correlation among boys was between MFR z-score and AST/ALT ratio (r = 0.530, p < 0.001), whereas the strongest correlation among girls was between fat percentage and NFS (r = 0.503, p < 0.001). Individuals with sonographic hepatic steatosis had higher fat mass (p = 0.003), lower MFR z-score (p = 0.020), greater insulin resistance (p = 0.018), and atherogenic dyslipidemic index (p = 0.037) compared to those without.
Conclusions: We identified sex differences in the association between body composition and hepatic fibrosis indices. The relationship between adverse body composition and increased odds of hepatic steatosis underscores the importance of its assessment within this at-risk population.
Keywords: bioelectrical impedance analysis (BIA); hepatic steatosis; indices of hepatic fibrosis; muscle‐to‐fat ratio (MFR); nonalcoholic fatty liver disease (NAFLD).
© 2025 The Author(s). Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Vajro P., Lenta S., Socha P., et al., “Diagnosis of Nonalcoholic Fatty Liver Disease in Children and Adolescents: Position Paper of the ESPGHAN Hepatology Committee,” Journal of Pediatric Gastroenterology and Nutrition 54, no. 5 (2012): 700–713. - PubMed
-
- Vos M. B., Abrams S. H., Barlow S. E., et al., “NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations From the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN),” Journal of Pediatric Gastroenterology and Nutrition 64, no. 2 (2017): 319–334. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
